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ABSTRACT: New methods for peptide modification are in high demand in drug discovery, chemical biology and materials chem-
istry; methods that modify natural peptides are particularly attractive. A Pd-catalyzed, C-H functionalization protocol for the ole-
fination of phenylalanine residues in peptides is reported, which is compatible with common amino acid protecting groups, and the 
scope of the styrene reaction partner is broad. Bidentate coordination of the peptide to the catalyst appears crucial for the success of 
the reaction. 
The chemical modification of peptides is critical to research 
in chemical biology and biomedicine, finding applications in 
advancing the understanding of biological function, the diag-
nosis and treatment of disease, and the manufacture of new 
materials.1,2 For example, peptides have been modified with 
tags for the imaging of biological systems, and with reporters 
for the study of biological mechanism.3-7 In drug discovery, 
peptide therapeutics are an attractive alternative to small mol-
ecule drugs, often possessing higher target specificity.8,9 Na-
tive peptides usually have poor pharmacological properties, 
but chemical modification can greatly improve binding affini-
ty to the target, stability of the peptide and cell penetration.10-13 
Although a large number of methods have been developed 
for the site-selective modification of peptides,2,14 these meth-
ods commonly rely upon the reactions of heteroatoms within a 
side-chain of the peptide, which are often important for bio-
logical function,15,16 or upon the incorporation of non-natural 
amino acids to facilitate the subsequent modification.17,18 
Hence, new methods for peptide modification that operate on 
the natural peptide, and at sites other than heteroatoms, are 
highly desirable. The post-synthetic modification of natural 
peptides and peptidomimetics has been recently achieved 
through the C-H functionalization of hydrophobic residues:19 
reactions have been reported that directly modify either tryp-
tophan or alanine resides.20-27 However, methods for the direct 
modification of phenylalanine (Phe) residues in peptides are 
lacking.2,28 Herein, we report a C-H olefination protocol for 
the direct post-synthetic modification of Phe containing pep-
tides; very recently, a complementary method for the C-H 
olefination of peptides has been communicated.29 
Inspired by previous research on the palladium-catalyzed 
Fujiwara-Moritani (oxidative-Heck) reaction,28a,30 we began by 
investigating the olefination of the model phenylalanine con-
taining dipeptide Ac-Gly-Phe-OMe (1a), Table 1. Treating 
dipeptide 1a with an equimolar amount of styrene, Pd(OAc)2 
(10 mol %) and AgOAc (2.5 equiv.) at 130 °C in a mixture of 
1,2-dichloroethane / DMF (15:1), gave the di-olefinated pep-
tide 2a in 19% isolated yield, entry 1. In the 1H NMR spec-
trum for 2a, the coupling constants for the alkene signals re-
vealed that the alkene was exclusively the trans geometry. 
Increasing the number of equivalents of styrene increased the 
isolated yield of 2a to 35%, entry 2; however, there was little 
benefit in using more than 4 equivalents of styrene in the reac-
tion, see Supporting Information. Next, we investigated the 
effect of the reaction solvent on the yield of 2: conducting the 
reaction in toluene, DMF or acetonitrile resulted in very simi-
lar yields (23-26%, entries 3-5). Hexafluoroisopropanol 
(HFIP), a solvent previously used to good effect in C-H func-
tionalizations, including peptides,24,31 gave only a trace yield 
of 2a, entry 6. The best solvent for the reaction proved to be 
tert-amyl alcohol; the use of this solvent increased the yield of 
2a to 67%, entry 7. Alternative oxidants were investigated for 
the reaction, including benzoquinone, Cu(OAc)2 and other 
silver salts, but none proved to be as competent as AgOAc. 
However, the best yield of 2a was achieved by increasing the 
amount of AgOAc to 5 equivalents (81%, entry 8), when the 
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• compatible with common protecting groups
• broad scope of styrene reaction partner
• bidentate coordination of peptide to Pd appears crucial
 reaction time could also be shortened to 12 h. Under these 
higher-yielding conditions, we were also able to isolate the 
mono-olefinated peptide 2aʹ in 8% yield. It was also possible 
to carry out the reaction at lower temperatures (entries 9 and 
10, 100 and 80 °C), but the yield was slightly reduced. 
Table 1. Optimisation of the C-H olefinationa 
 
entry equiv. 
styrene 
equiv. 
AgOAc 
solvent T / °C time  
/ h 
yield  
/ % 
1 1 2.5 DCE/DMFb 130 48 19 
2 4 2.5 DCE/DMFb 130 48 35 
3 4 2.5 PhMe 130 48 26 
4 4 2.5 DMF 130 48 26 
5 4 2.5 MeCN 130 48 23 
6 4 2.5 HFIP 130 48 trace  
7 4 2.5 t-amylOH 130 48 67 
8 4 5 t-amylOH 130 12 81c 
9 4 5 t-amylOH 100 12 76 
10 4 5 t-amylOH   80 12 68 
aFull details of the optimisation study are provided in the Sup-
porting Information; bDCE/DMF = 15:1; cThe mono-olefinated 
peptide 2aʹ was also isolated in 8% yield. 
Having determined the optimum conditions for the olefina-
tion of dipeptide 1a, we next investigated the effect of the 
nitrogen protecting group on the reaction, Scheme 1. This 
study demonstrated the compatibility of protecting groups 
commonly used in peptide synthesis. Although the original 
acetyl protecting group gave the best yield, the use of the car-
bamate protecting groups Boc, Fmoc and Cbz also provided 
the di-olefinated peptide in moderate to good yields (52-71%). 
There was no evidence for C-H functionalization of the aro-
matic C-H bonds in the Fmoc and CBz protecting groups. 
Intriguingly, protecting the glycine nitrogen as the phthalimide 
prevented any C-H functionalization of the peptide; in combi-
nation with other experiments, this outcome proved useful in 
delineating a mechanism for the reaction, vide infra. 
Scheme 1. Scope of the N-protecting group for the C-H 
olefination of Gly-Phe dipeptides. 
 
With a view to future applications in chemical biology, we 
next investigated the scope of the alkene. For the C-H olefina-
tion of dipeptide 1a, we studied the reaction with a range of 
styrene derivatives, Scheme 2. Electron-withdrawing (F–, Cl–, 
Br–, F3C–, NC–, O2N–) and electron-donating substituents 
(H3C–, MeO–) were compatible with the reaction; moreover, 
the incorporation of halogen atoms potentially enables further 
functionalization of the peptide.32 Alkenes possessing more 
extensive conjugation were also tolerated (4-phenylstyrene 
and 2-vinylnaphthalene); tailoring the extent of π-conjugation 
can be important when modifying peptides for fluorescence 
imaging.33  
Scheme 2. Scope of the alkene for the C-H olefination of 
model dipeptide 1a. 
 
Next, we examined the scope of the amino acid at the N-
terminus of the dipeptide, Scheme 3. The aliphatic amino ac-
ids Ala, Leu, Ile, Val all proved amenable to the reaction (5a-
d), as was methionine (Met, 5e), which possesses a thioether 
side-chain;34 isolated yields ranged from 60-76% for the modi-
fication of these dipeptides. NMR and HPLC data confirmed 
that the peptide was not racemized during the reaction, see 
Supporting Information. The reaction did also proceed with 
proline (Pro) as the adjacent residue, but the yield was much 
lower (24%). The reduced yield in the synthesis of 5f could be 
attributed to the tertiary amide group of proline, which may be 
a less capable ligand for the Pd catalyst, or to the conforma-
tional constraint imparted by the Pro residue. 
For the reaction of the peptide Ac-Phe-Phe-OMe (4g), we 
were interested to see if olefination would take place on both 
phenylalanine residues. From this reaction of 4g, the modified 
peptide 5g was obtained, in which only the phenylalanine resi-
due at the C-terminus had undergone C-H olefination. Conse-
quently, we prepared the dipeptide Ac-Phe-Gly-OMe (4h) to 
determine if modification of Phe at the N-terminus was possi-
ble in the absence of phenylalanine at the C-terminus, Eq. 1: 
dipeptide 4h proved to be unaltered under the conditions of the 
C-H olefination reaction.35 
To evaluate the potential of the olefination reaction for the 
modification of longer peptides, we surveyed the C-H olefina-
tion of a range of tri- and tetra-peptides, Scheme 4. For the 
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 tripeptides, di-olefination occurred for phenylalanine residues 
in the middle of the peptide chain or at the C-terminus (8a, 
8b), but not at the N-terminus (8c was not obtained). Tetrapep-
tides with a Phe residue were also successfully modified by 
the reaction (9a-c). 
Scheme 3. Scope of the amino acid at the N-terminus of 
dipeptides. 
 
 
Why does the reaction not proceed when the phenylalanine 
residue is at the N-terminus of the peptide? A key feature of 
the peptide is that it can coordinate to the Pd-catalyst through 
amide groups of the peptide backbone, and hence facilitate the 
C-H functionalization. As there is more than one amide group 
in the peptide, several distinct coordination modes are possi-
ble. Prior calculations have demonstrated that a bidentate di-
recting group can stabilize intermediates and transition states 
in C-H activation.36 Here we propose that the peptide coordi-
nates to Pd through two nitrogen atoms, and when the Phe 
residue is not at the N-terminus of the peptide, this coordina-
tion mode offers a low energy pathway for C-H activation, 
Scheme 5(a).37 
Scheme 4. C-H olefination of tri- and tetra-peptides. 
 
In contrast, if the Phe residue is situated at the N-terminus, 
bidentate coordination of the peptide means that C-H activa-
tion is geometrically unfeasible at square planar Pd(II), 
Scheme 5(b). In this latter case, C-H activation can only pro-
ceed through a monodentate intermediate. Presumably this 
higher energy pathway is inaccessible under the reaction con-
ditions. 
In summary, we have developed an efficient peptide modi-
fication protocol that employs the Fujiwara-Moritani reaction 
to functionalize phenylalanine residues in peptides. Specifical-
ly, Phe containing peptides have been modified by reaction 
with styrene derivatives in the presence of Pd(OAc)2 catalyst 
and Ag(OAc); good yields of the di-olefinated peptide were 
achieved at a temperature of 80 °C, but the best yields were 
obtained at 130 °C. This protocol is complementary to previ-
ously reported methods for the C-H functionalization of tryp-
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 tophan and alanine residues. A range of styrene derivatives 
were used in the reaction, and several of these can enable fur-
ther chemistry to be carried out on the modified peptide. The 
chemistry we describe offers new opportunities for the devel-
opment of peptide pharmaceuticals or for application in chem-
ical biology; we are currently pursuing applications in these 
areas. 
Scheme 5. Proposed effect of peptide binding mode on C-H 
activation. 
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